A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist
Clinical trial NCT02808819 · COMPLETED
Trial details
- NCT number
- NCT02808819
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-30
- Primary completion
- 2020-06-18
- Enrollment
- 447
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.